Arfon G M T Powell1, Catherine Eley2, Carven Chin2, Alexandra H Coxon2, Adam Christian3, Wyn G Lewis2. 1. Division of Cancer and Genetics, University Hospital of Wales, Cardiff University, Heath Park, Cardiff, UK. powella16@cardiff.ac.uk. 2. Department of Surgery, Cardiff & Vale University Health Board, University Hospital of Wales, Heath Park, Cardiff, UK. 3. Department of Pathology, Cardiff & Vale University Health Board, University Hospital of Wales, Heath Park, Cardiff, UK.
Abstract
BACKGROUND: The aim of this study was to assess the relative prognostic value of biomarkers to measure the systemic inflammatory response (SIR) and potentially improve prognostic modeling in patients undergoing potentially curative surgery for esophageal adenocarcinoma (EC). METHODS: Consecutive 330 patients undergoing surgery for EC between 2004 and 2018 within a regional UK cancer network were identified. Serum measurements of haemoglobin, C-reactive protein, albumin, modified Glasgow Prognostic Score (mGPS), and differential neutrophil to lymphocyte ratio (NLR) were obtained before surgery, and correlated with histopathological factors and outcomes. Primary outcome measures were disease-free (DFS) and overall survival (OS). RESULTS: Of 330 OC patients, 294 underwent potentially curative esophagectomy. Univariable DFS analysis revealed pT, pN, pTNM stage (all p < 0.001), poor differentiation (p = 0.001), vascular invasion (p < 0.001), R1 status (p < 0.001), perioperative chemotherapy (p = 0.009), CRP (p = 0.010), mGPS (p = 0.011), and NLR (p < 0.001), were all associated with poor survival. Multivariable Cox regression analysis of DFS revealed only NLR [Hazard Ratio (HR) 3.63, 95% Confidence Interval (CI) 2.11-6.24, p < 0.001] retained significance. Multivariable Cox regression analysis of OS revealed similar findings: NLR [HR 2.66, (95% CI 1.58-4.50), p < 0.001]. CONCLUSION: NLR is an important SIR prognostic biomarker associated with DFS and OS in EC.
BACKGROUND: The aim of this study was to assess the relative prognostic value of biomarkers to measure the systemic inflammatory response (SIR) and potentially improve prognostic modeling in patients undergoing potentially curative surgery for esophageal adenocarcinoma (EC). METHODS: Consecutive 330 patients undergoing surgery for EC between 2004 and 2018 within a regional UK cancer network were identified. Serum measurements of haemoglobin, C-reactive protein, albumin, modified Glasgow Prognostic Score (mGPS), and differential neutrophil to lymphocyte ratio (NLR) were obtained before surgery, and correlated with histopathological factors and outcomes. Primary outcome measures were disease-free (DFS) and overall survival (OS). RESULTS: Of 330 OC patients, 294 underwent potentially curative esophagectomy. Univariable DFS analysis revealed pT, pN, pTNM stage (all p < 0.001), poor differentiation (p = 0.001), vascular invasion (p < 0.001), R1 status (p < 0.001), perioperative chemotherapy (p = 0.009), CRP (p = 0.010), mGPS (p = 0.011), and NLR (p < 0.001), were all associated with poor survival. Multivariable Cox regression analysis of DFS revealed only NLR [Hazard Ratio (HR) 3.63, 95% Confidence Interval (CI) 2.11-6.24, p < 0.001] retained significance. Multivariable Cox regression analysis of OS revealed similar findings: NLR [HR 2.66, (95% CI 1.58-4.50), p < 0.001]. CONCLUSION: NLR is an important SIR prognostic biomarker associated with DFS and OS in EC.
Authors: T Cederholm; G L Jensen; M I T D Correia; M C Gonzalez; R Fukushima; T Higashiguchi; G Baptista; R Barazzoni; R Blaauw; A Coats; A Crivelli; D C Evans; L Gramlich; V Fuchs-Tarlovsky; H Keller; L Llido; A Malone; K M Mogensen; J E Morley; M Muscaritoli; I Nyulasi; M Pirlich; V Pisprasert; M A E de van der Schueren; S Siltharm; P Singer; K Tappenden; N Velasco; D Waitzberg; P Yamwong; J Yu; A Van Gossum; C Compher Journal: Clin Nutr Date: 2018-09-03 Impact factor: 7.324
Authors: Arfon G M T Powell; Debora Parkinson; Neil Patel; David Chan; Adam Christian; Wyn G Lewis Journal: J Gastrointest Surg Date: 2017-10-04 Impact factor: 3.452
Authors: Cliona M Lorton; Larissa Higgins; Niamh O'Donoghue; Claire Donohoe; Jim O'Connell; David Mockler; John V Reynolds; Declan Walsh; Joanne Lysaght Journal: Ann Surg Oncol Date: 2021-11-12 Impact factor: 5.344
Authors: Li Chen; Ping Bai; Xiangyi Kong; Shaolong Huang; Zhongzhao Wang; Xiangyu Wang; Yi Fang; Jing Wang Journal: Front Cell Dev Biol Date: 2021-03-30